Health News
Acupuncture May Not Reduce Knee Pain
Chronic knee pain is one of the most common complaints people older than 50 bring to their doctors, and many doctors and patients may prefer to use treatments that do not involve medication. But acupuncture may not be an effective alternative.
Experts Say Opioids May Not Be Worth Risk for Some Conditions
In recent years, opioids have become a safety concern for some health officials. The American Academy of Neurology (AAN) recently released a statement on opioid use to address this problem.
Ice Pack For Freezing Surgical Pain
Lessening the pain that frequently follows major abdominal surgery is critical as patients begin their recovery. Strong, pain-relieving opioid medications typically are prescribed at the start of that healing process.
FDA Requiring Color Changes to Duragesic Pain Patches to Aid Safety
The US Food and Drug Administration (FDA) is requiring color changes to the writing on Duragesic (fentanyl) pain patches so they can be seen more easily.
From Ouch! To Say What?
Many women use over-the-counter pain relievers for the aches and pains of daily living. But they may not track how many they take over a week. It might be a good idea to start.
FDA Issues Warning on Natural Supplement
There are countless dietary supplements marketed as natural remedies for pain relief. In some instances, these supplements turn out to be neither natural nor safe, which seems to be the case for Reumofan Plus.
FDA Issues Alert on Reumofan Plus
The U.S. Food and Drug Administration is warning consumers that Reumofan Plus, marketed as a “natural” dietary supplement for pain relief and other serious conditions, contains several active pharmaceutical ingredients not listed on the label that could be harmful.
Hospira Alert: Carpuject May Contain More Than the Intended Fill Volume
FDA is alerting healthcare providers of a potential safety risk in some Carpuject pre-filled cartridges manufactured by Hospira , Inc.
Multiple Diseases, Multiple Problems
In the age of multitasking, “one thing at a time” is as outdated as a polyester leisure suit. The same is true for doctors treating just one disease as it can lead to confusion and inferior care.
Pfizer Stops Phase 3 Trial Of Lyrica
Pfizer Inc. announced that it has stopped a Phase 3 clinical trial of Lyrica ( pregabalin ) in patients with neuropathic pain associated with HIV neuropathy, a form of nerve damage characterized by burning pain usually beginning in the feet.